Riya Pahuja
Riya covers B2B applications of machine learning for Emerj - across North America and the EU. She has previously worked with the Times of India Group, and as a journalist covering data analytics and AI. She resides in Toronto.
Articles by Riya
30 articles
The "buy versus build" debate is central to digital transformation, particularly in AI adoption, and hinges on an organization's unique goals and industry context.
This interview analysis is sponsored by MinIO and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
Gilead Sciences, a biopharmaceutical company founded in 1987, has emerged as a leader in the development of innovative therapies for a range of diseases, including HIV, liver diseases, and oncology. With a commitment to advancing the field of medicine, Gilead has increasingly recognized the vital role that AI plays in its operations. Gilead Sciences achieved an annual revenue of approximately $28.3 billion in 2024, driven by its robust portfolio, and employs around 18,000 people globally, reflecting its substantial size and reach within the biotech industry.
From intelligent sourcing and predictive analytics to automated contract analysis and risk mitigation, AI is enabling procurement teams to focus on strategic activities while delivering significant cost savings and improved supplier relationships.
This interview analysis is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This interview analysis is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
American Family Insurance Group, founded in 1927, began as Farmers Mutual Insurance Company in Madison, Wisconsin, targeting farmers with auto insurance. Over the decades, it expanded its offerings and changed its name to American Family Mutual Insurance Company in 1963. As per the financials published by the company, it made $17.1 billion in revenue in 2023, up from $14.4 billion in 2022.
This article is sponsored by Pieces and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This article is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This article is sponsored by Interactions and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
Unlike other industrial sectors, many healthcare systems and services are embracing the roadblocks in their technological adoption processes. Thoroughly vetting systems is far more critical for most forms of patient care than having the latest and greatest technology.
This interview analysis is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This interview analysis is sponsored by Pieces and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
As technology advances, the lines between mobile applications and medical devices are blurring in ways that have healthcare leaders, software developers, and regulators alike facing new and unprecedented challenges.
Boeing, founded in 1916, is a global aerospace company and one of the largest aircraft manufacturers in the world. Headquartered in Arlington, Virginia, the company operates in commercial airplanes, defense, space, and security sectors.
This interview analysis is sponsored by Aquant and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This interview analysis is sponsored by Capgemini and was written, edited, and published in alignment with our Emerj-sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This article is sponsored by LeddarTech and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
This interview analysis is sponsored by Pieces and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
Blue Cross Blue Shield (BCBS) is a federation of 35 independent health insurance companies that provide coverage to over 100 million Americans. The organization's national headquarters is located in Chicago, Illinois, while individual BCBS companies operate in various states across the country.
This interview analysis is sponsored by CLARA Analytics and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
GEICO (Government Employees Insurance Company) is one of the largest auto insurance providers in the United States. Founded in 1936, it has grown to become a significant player in the insurance industry under the ownership of Berkshire Hathaway.
This article is sponsored by LeddarTech and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
The Software-as-a-Service (SaaS) model has experienced remarkable growth in the fintech sector over the past decade. According to research from Boston Consulting Group, fintech revenues are projected to increase sixfold by 2030, reaching $1.5 trillion.
In managing public sector projects, success hinges on strategic planning and innovative practices. Challenges such as budget constraints, communication issues, and resource limitations must be addressed through effective communication, precise resource allocation, and the strategic use of technology. Implementing digital upskilling programs can bridge the skills gap, while cloud-based solutions boost efficiency.
Driving Development Efficiencies for Saas – with Akash Gupta of GreyOrange and Tsavo Knott of Pieces
This interview analysis is sponsored by Pieces and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.
Lilly and Company is a global pharmaceutical corporation founded in 1876 and headquartered in Indianapolis, Indiana. The company has offices in 18 countries and sells its products in approximately 125 countries worldwide. As of 2024, Lilly employs over 38,000 people globally and has an annual revenue of $34.12 billion.
Explainable AI models are essential in pharmaceutical R&D because they provide transparency and understanding of how AI-driven predictions are made. In drug discovery and development, stakeholders, including researchers, regulatory bodies, and healthcare professionals, need to trust and understand AI models' outputs to make informed decisions. Without explainability, AI models can be seen as "black boxes," leading to skepticism and reluctance to adopt these technologies in critical decision-making processes.
Fostering a culture of experimentation in AI and data science is crucial for organizations to stay competitive and drive innovation. In 2021, an MIT Sloan report found companies that prioritize AI experimentation are 2.7 times more likely to capture new value and improve their operations. By embracing a more experimental mindset, organizations can harness the full potential of AI-driven tools and unlock new opportunities for growth.
This article/interview analysis is sponsored by BenevolentAI and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.